Cencora Raises Fiscal 2026 Adjusted Diluted EPS Outlook to at Least $17.90

• Cencora now expects fiscal 2026 adjusted diluted EPS of at least $17.90, versus its previous $17.75-$17.95 range.
• The revised outlook reflects strength in its U.S. Healthcare Solutions segment.
• Its planned American Oncology Network acquisition carries a $2.4 billion enterprise value, including up to $100 million in contingent value rights.
• The acquisition is expected to lift adjusted diluted EPS in the second year following closing.
• Fiscal 2027 expectations will be discussed on the fiscal fourth-quarter 2026 earnings call on November 4, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cencora Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610210730BIZWIRE_USPR_____20261020_BW319270) on October 21, 2026, and is solely responsible for the information contained therein.